Request Info


Ask for our annual reports or more information
Email Us

Email Alerts

Sign up for email alerts
Email Alerts
Investor Relations

SEC Filings

RSS RSS Feeds
Form 10-K
MERIDIAN BIOSCIENCE INC filed this Form 10-K on 11/29/2016
Document Outline
Entire Document (3939.9 KB)
Subdocument 1 - 10-K - ANNUAL REPORT
Page 1 - SECURITIES AND EXCHANGE COMMISSION
Page 2 - N/A
Page 3 - N/A
Page 4 - Card
Page 5 - www.meridianbioscience.com
Page 6 - N/A
Page 7 - illumi
Page 8 - Sales, Marketing and Distribution
Page 9 - Competition
Page 10 - Intellectual Property, Patents and Licenses
Page 11 - Medical Device Tax
Page 12 - Life Science Segment
Page 13 - Market Trends
Page 14 - International Markets
Page 15 - We may be unable to successfully integrate operations or to achieve expected cost savings from acqui
Page 16 - Seasonal Factors and Sporadic Outbreaks
Page 17 - Efforts to reduce the U.S. federal deficit could adversely affect our results of operations.
Page 18 - We may face increased competition resulting from expiration of our H. pylori patents.
Page 19 - Significant interruptions in production at our principal manufacturing facilities and/or third-party
Page 20 - illumi
Page 21 - If product liability lawsuits are successfully brought against us, we may incur substantial liabilit
Page 22 - We face risks related to global economic conditions.
Page 23 - Natural disasters, war and other events could adversely affect our future revenues and operating inc
Page 24 - LEGAL PROCEEDINGS
Page 25 - MARKET FOR REGISTRANT S COMMON
Page 26 - MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL
Page 27 - C. difficile
Page 28 - N/A
Page 29 - Revenue Overview- By Product Platform/Type
Page 30 - illumi
Page 31 - H. pylori
Page 32 - Foreign Currency
Page 33 - Operating Expenses:
Page 34 - Fiscal 2015 increase
Page 35 - Other Income and Expense
Page 36 - N/A
Page 37 - Capital Resources
Page 38 - Other Commitments and Off-Balance Sheet Arrangements:
Page 39 - Critical Accounting Policies:
Page 40 - Inventories
Page 41 - Income Taxes
Page 42 - Balance Sheet Classification of Deferred Taxes
Page 43 - Intra-Entity Transfers of Assets Other Than Inventory
Page 44 - FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Page 45 - Management s Report on Internal Control over Financial Reporting
Page 46 - REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 47 - REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 48 - Internal Control Integrated Framework
Page 49 - CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data)
Page 50 - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (dollars in thousands)
Page 51 - CONSOLIDATED BALANCE SHEETS (dollars in thousands)
Page 52 - CONSOLIDATED BALANCE SHEETS (dollars in thousands)
Page 53 - CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (dollars and shares in thousands, except per share da
Page 54 - CONSOLIDATED STATEMENTS OF CASH FLOWS (dollars in thousands)
Page 55 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Page 56 - N/A
Page 57 - N/A
Page 58 - N/A
Page 59 - illumi
Page 60 - N/A
Page 61 - Balance Sheet Classification of Deferred Taxes
Page 62 - Improvements to Employee Share-Based Payment Accounting
Page 63 - N/A
Page 64 - N/A
Page 65 - N/A
Page 66 - N/A
Page 67 - N/A
Page 68 - N/A
Page 69 - N/A
Page 70 - N/A
Page 71 - N/A
Page 72 - N/A
Page 73 - illumi
Page 74 - N/A
Page 75 - N/A
Page 76 - N/A
Page 77 - CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
Page 78 - EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
Page 79 - N/A
Page 80 - N/A
Page 81 - N/A
Page 82 - Year Ended September 30, 2016:
Subdocument 2 - EX-10.9 - EX-10.9
Page 1 - Exhibit 10.9
Page 2 - FY 2017 Published Net Earnings Guidance Range Diluted EPS of $******
Page 3 - Calculation
Subdocument 3 - EX-10.10 - EX-10.10
Page 1 - Exhibit 10.10
Page 2 - 3. Forfeiture of Restricted Units.
Page 3 - 10. Relation to Other Benefits.
Page 4 - 20. Governing Law.
Page 5 - N/A
Subdocument 4 - EX-10.11 - EX-10.11
Page 1 - Exhibit 10.11
Page 2 - N/A
Page 3 - seventh
Page 4 - N/A
Page 5 - forum non conveniens
Subdocument 5 - EX-13 - EX-13
Page 1 - Exhibit 13
Page 2 - N/A
Page 3 - Corporate Data
Page 4 - PERFORMANCE GRAPH
Subdocument 6 - EX-21 - EX-21
Page 1 - Exhibit 21
Subdocument 7 - EX-23 - EX-23
Page 1 - Exhibit 23
Subdocument 8 - EX-31.1 - EX-31.1
Page 1 - Exhibit 31.1
Subdocument 9 - EX-31.2 - EX-31.2
Page 1 - Exhibit 31.2
Subdocument 10 - EX-32 - EX-32
Page 1 - Exhibit 32
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (What's this?)
XBRL Viewer